Document is current

Article History

Received: 14 August 2024

Accepted: 4 September 2024

First Online: 25 September 2024

Declarations

:

: The study protocol and the amendment were reviewed by the Independent Ethics Committee (IEC) for each study center. Leading ethics committee was the Ethics Committee of the Medical Faculty of Kiel University. APOLLON was conducted according to ICH E6 Guideline for Good Clinical Practice that have their origin in the Declaration of Helsinki. Informed consent was obtained from each subject in writing before any study specific procedure was performed. The study was explained to the subject by the investigator or designee, who answered any questions, and written information was also provided.

: Consent for publication was received.

: HG received financial compensation for consulting and speaker activities from Allergan, Almirall, Astra Zeneca, Bayer Vital, Berlin Chemie, Bionorica, Bristol Myers Squibb, Elli Lilly, Fujisawa, GlaxoSmithKline, Grünenthal, Hermal, Hormosan, Ipsen Pharma, Janssen Cilag, Johnson&Johnson, Krewel Meuselbach, Klosterfrau, Lichtwer, Menarini Pharma, Merz Pharmaceuticals, Minster Pharmaceuticals, MSD, Novartis Pharma, Pfizer, Pharmacia, Sandoz, Schaper und Brümmer, Schwarz Pharma, Teva, Weber&Weber, Smith Kline Beecham. ES received financial compensation for consulting and speaker activities from Novartis Pharma, Merck, Biogen, Abbvie, Roche. KJ, LL and SO are employees of Novartis Pharma GmbH, Nuremberg, Germany.